Biomarkers

Photo

News • Proteins for personalized treatments

Tracking Duchenne muscular dystrophy with blood biomarkers

Newly discovered blood biomarkers may offer new options to track Duchenne muscular dystrophy (DMD) in a less invasive way than physical tests or biopsies. This could support more tailored treatments.

Photo

News • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Blood test for ME/CFS unveiled

Chronic fatigue (ME/CFS) affects millions worldwide, but is poorly understood and has long lacked reliable diagnostic tools. Now, a new blood test claims to diagnose the condition with 96% accuracy.

Photo

News • Endocrinology

European study establishes leptin reference values across age groups

International research led by Leipzig and Ulm universities creates first standardized leptin reference values for all ages and weight classes, advancing personalized medicine

Photo

News • Diagnostics

Fast candida detection through sugar pattern analysis

Scientists created precise replicas of Candida sugar coats to understand immune responses, enabling fast bedside testing that could replace slow lab cultures.

Photo

News • Evaluating tadiotheranostic targets

Endometrial cancer: new markers for PET imaging

Researchers explored two promising new biomarkers as potential radiotheranostic targets for endometrial cancer. This could help identify patients who are likely to respond to targeted therapeutics.

Photo

News • Epigenetic biomarkers

Revealing risk of cardiovascular disease in type 2 diabetes

Type 2 diabetes greatly increases the risk of heart attacks, strokes, anginas, and other coronary heart diseases. Therefore, biomarkers to predict individual risk are needed, experts say.

Photo

Article • Detection of neurodegenerative condition

Developing blood biomarkers to diagnose Alzheimer’s disease

There is no known cure for Alzheimer’s disease (AD), although prescription drug-based treatments that can slow AD progression in some patients are starting to enter clinical use. Biomarkers, quantifiable characteristics of biological processes or pathological conditions of the body, are making it possible to help identify and measure the presence and extent of AD and its degenerative…

Photo

Article • Promising, but in need of further validation

Implementation challenges of blood biomarkers for Alzheimer’s disease

Blood-based biomarker (BBB) tests may represent the best weapon to combat the soaring rates of Alzheimer’s disease (AD) throughout the world. Existing clinically validated tests are currently deployed to facilitate diagnosis, to monitor disease and effectiveness of treatments, to quantify progression, and to determine if a patient is appropriate for treatment or participation in a clinical…

143 show more articles
Subscribe to Newsletter